Cargando…

The impact of COVID‐19 on the management of neuroendocrine tumors (NETS): An international NET CONNECT survey of NET patients and healthcare professionals treating net patients

The COVID‐19 outbreak has added complexity in the management of patients with neuroendocrine tumors (NETs). Little information is currently available regarding the real impact of the pandemic in current practice. The present study aimed to capture patients' and healthcare professionals' ex...

Descripción completa

Detalles Bibliográficos
Autores principales: Cives, Mauro, Hernando, Jorge, Lamarca, Angela, Bouvier, Catherine, Caplin, Martyn, Pavel, Marianne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9786666/
https://www.ncbi.nlm.nih.gov/pubmed/36072989
http://dx.doi.org/10.1111/jne.13196
_version_ 1784858341049106432
author Cives, Mauro
Hernando, Jorge
Lamarca, Angela
Bouvier, Catherine
Caplin, Martyn
Pavel, Marianne
author_facet Cives, Mauro
Hernando, Jorge
Lamarca, Angela
Bouvier, Catherine
Caplin, Martyn
Pavel, Marianne
author_sort Cives, Mauro
collection PubMed
description The COVID‐19 outbreak has added complexity in the management of patients with neuroendocrine tumors (NETs). Little information is currently available regarding the real impact of the pandemic in current practice. The present study aimed to capture patients' and healthcare professionals' experiences on how the NET management has changed during the pandemic and how it should be modified in a foreseeable post‐pandemic environment. Physicians and nurses working in ENETS Centers of Excellence or other hospitals with high volume of NET patients (n = 48), as well as NET patients residing worldwide (n = 353), were asked to respond to two online anonymous surveys addressing different aspects of NET care. Deferred diagnoses, delayed surveillance procedures and postponed elective surgeries were among the main negative consequences of the COVID‐19 outbreak according to 40%, 54% and 46% of healthcare professionals (HPs) respectively. Somatostatin analogs were increasingly used as bridging strategy for delaying surgery based on the views of 31% of HPs and were self‐injected or delivered by home care services more frequently than before the initiation of the pandemic (53% of patients during the pandemic vs. 44% before the pandemic). Multidisciplinary tumor boards kept their usual schedule according to 58% of HPs, but were held virtually in the 77% of cases. The contact with healthcare professionals was maintained by remote methods more often than in the past (69% of patients), but only 34% of patients (59% among subjects < 41 years) would prefer telemedicine to face‐to‐face consultations in the future. New health policy measures should guarantee the highest standard of treatment to NET patients, regardless of the trajectory followed by the COVID‐19 pandemic in the next months. Pros and cons of telemedicine should be carefully weighted before systematic implementation.
format Online
Article
Text
id pubmed-9786666
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-97866662022-12-27 The impact of COVID‐19 on the management of neuroendocrine tumors (NETS): An international NET CONNECT survey of NET patients and healthcare professionals treating net patients Cives, Mauro Hernando, Jorge Lamarca, Angela Bouvier, Catherine Caplin, Martyn Pavel, Marianne J Neuroendocrinol Translational and Clinical Neuroendocrinology The COVID‐19 outbreak has added complexity in the management of patients with neuroendocrine tumors (NETs). Little information is currently available regarding the real impact of the pandemic in current practice. The present study aimed to capture patients' and healthcare professionals' experiences on how the NET management has changed during the pandemic and how it should be modified in a foreseeable post‐pandemic environment. Physicians and nurses working in ENETS Centers of Excellence or other hospitals with high volume of NET patients (n = 48), as well as NET patients residing worldwide (n = 353), were asked to respond to two online anonymous surveys addressing different aspects of NET care. Deferred diagnoses, delayed surveillance procedures and postponed elective surgeries were among the main negative consequences of the COVID‐19 outbreak according to 40%, 54% and 46% of healthcare professionals (HPs) respectively. Somatostatin analogs were increasingly used as bridging strategy for delaying surgery based on the views of 31% of HPs and were self‐injected or delivered by home care services more frequently than before the initiation of the pandemic (53% of patients during the pandemic vs. 44% before the pandemic). Multidisciplinary tumor boards kept their usual schedule according to 58% of HPs, but were held virtually in the 77% of cases. The contact with healthcare professionals was maintained by remote methods more often than in the past (69% of patients), but only 34% of patients (59% among subjects < 41 years) would prefer telemedicine to face‐to‐face consultations in the future. New health policy measures should guarantee the highest standard of treatment to NET patients, regardless of the trajectory followed by the COVID‐19 pandemic in the next months. Pros and cons of telemedicine should be carefully weighted before systematic implementation. John Wiley and Sons Inc. 2022-09-07 2022-10 /pmc/articles/PMC9786666/ /pubmed/36072989 http://dx.doi.org/10.1111/jne.13196 Text en © 2022 The Authors. Journal of Neuroendocrinology published by John Wiley & Sons Ltd on behalf of British Society for Neuroendocrinology. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Translational and Clinical Neuroendocrinology
Cives, Mauro
Hernando, Jorge
Lamarca, Angela
Bouvier, Catherine
Caplin, Martyn
Pavel, Marianne
The impact of COVID‐19 on the management of neuroendocrine tumors (NETS): An international NET CONNECT survey of NET patients and healthcare professionals treating net patients
title The impact of COVID‐19 on the management of neuroendocrine tumors (NETS): An international NET CONNECT survey of NET patients and healthcare professionals treating net patients
title_full The impact of COVID‐19 on the management of neuroendocrine tumors (NETS): An international NET CONNECT survey of NET patients and healthcare professionals treating net patients
title_fullStr The impact of COVID‐19 on the management of neuroendocrine tumors (NETS): An international NET CONNECT survey of NET patients and healthcare professionals treating net patients
title_full_unstemmed The impact of COVID‐19 on the management of neuroendocrine tumors (NETS): An international NET CONNECT survey of NET patients and healthcare professionals treating net patients
title_short The impact of COVID‐19 on the management of neuroendocrine tumors (NETS): An international NET CONNECT survey of NET patients and healthcare professionals treating net patients
title_sort impact of covid‐19 on the management of neuroendocrine tumors (nets): an international net connect survey of net patients and healthcare professionals treating net patients
topic Translational and Clinical Neuroendocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9786666/
https://www.ncbi.nlm.nih.gov/pubmed/36072989
http://dx.doi.org/10.1111/jne.13196
work_keys_str_mv AT civesmauro theimpactofcovid19onthemanagementofneuroendocrinetumorsnetsaninternationalnetconnectsurveyofnetpatientsandhealthcareprofessionalstreatingnetpatients
AT hernandojorge theimpactofcovid19onthemanagementofneuroendocrinetumorsnetsaninternationalnetconnectsurveyofnetpatientsandhealthcareprofessionalstreatingnetpatients
AT lamarcaangela theimpactofcovid19onthemanagementofneuroendocrinetumorsnetsaninternationalnetconnectsurveyofnetpatientsandhealthcareprofessionalstreatingnetpatients
AT bouviercatherine theimpactofcovid19onthemanagementofneuroendocrinetumorsnetsaninternationalnetconnectsurveyofnetpatientsandhealthcareprofessionalstreatingnetpatients
AT caplinmartyn theimpactofcovid19onthemanagementofneuroendocrinetumorsnetsaninternationalnetconnectsurveyofnetpatientsandhealthcareprofessionalstreatingnetpatients
AT pavelmarianne theimpactofcovid19onthemanagementofneuroendocrinetumorsnetsaninternationalnetconnectsurveyofnetpatientsandhealthcareprofessionalstreatingnetpatients
AT civesmauro impactofcovid19onthemanagementofneuroendocrinetumorsnetsaninternationalnetconnectsurveyofnetpatientsandhealthcareprofessionalstreatingnetpatients
AT hernandojorge impactofcovid19onthemanagementofneuroendocrinetumorsnetsaninternationalnetconnectsurveyofnetpatientsandhealthcareprofessionalstreatingnetpatients
AT lamarcaangela impactofcovid19onthemanagementofneuroendocrinetumorsnetsaninternationalnetconnectsurveyofnetpatientsandhealthcareprofessionalstreatingnetpatients
AT bouviercatherine impactofcovid19onthemanagementofneuroendocrinetumorsnetsaninternationalnetconnectsurveyofnetpatientsandhealthcareprofessionalstreatingnetpatients
AT caplinmartyn impactofcovid19onthemanagementofneuroendocrinetumorsnetsaninternationalnetconnectsurveyofnetpatientsandhealthcareprofessionalstreatingnetpatients
AT pavelmarianne impactofcovid19onthemanagementofneuroendocrinetumorsnetsaninternationalnetconnectsurveyofnetpatientsandhealthcareprofessionalstreatingnetpatients